Daptomycin-induced eosinophilic pneumonia: Are there any risk factors? - 23/09/21
, Guillaume Beltramo a, b, c, Nicolas Aswad a, Yasmina Hassani a, Philippe Bonniaud a, b, cBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Daptomycin dose is not associated with the occurrence of eosinophilic pneumonia. |
• | Daptomycin dose is not associated with the timing of the onset of eosinophilic pneumonia. |
• | Age is not associated with the occurrence of eosinophilic pneumonia. |
• | Patients often present with associated diabetes and renal impairment. |
Abstract |
Objectives |
Daptomycin is a widely used antibiotic. Rhabdomyolysis related to daptomycin is one of the adverse effects of treatment, justifying the need for regular monitoring of muscle enzymes throughout treatment. Daptomycin may also lead to eosinophilic pneumonia. However, risk factors for this adverse reaction have not been identified and do not permit targeting of at-risk populations who could benefit from appropriate monitoring.
Patients and methods |
Literature was reviewed for cases of daptomycin-induced eosinophilic pneumonia (DIEP), which that were compared to cases of patients without this adverse effect.
Results |
Fifty patients with DIEP and 54 controls were identified. Age, sex, and treatment dose are not associated with the occurrence of DIEP. A high dose of daptomycin is not associated with an early onset of DIEP. About one third of patients with eosinophilic lung disease have diabetes or renal impairment.
Conclusions |
Further studies may help to identify additional factors.
Le texte complet de cet article est disponible en PDF.Keywords : Daptomycin, Pulmonary eosinophilia, Risk factor
Plan
Vol 51 - N° 7
P. 618-621 - octobre 2021 Retour au numéro
Article précédent
- Immunothérapie adoptive pour une infection à adénovirus non contrôlée chez un adulte avec transplantation allogénique de cellules souches hématopoïétiques
- G. Destras, A. Gaymard, G. Fossard, S. Ducastelle, C. Laroye, F. Ader, E. Frobert
- Infective endocarditis due to Neisseria elongata: A case report and literature review
- M. Banjari, E. Haddad, I. Bonnet, L. Legrand, F. Cohen, E. Caumes, V. Pourcher
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?